Cardiac Blood Test Predicts Post-Operative Complications
By HospiMedica International staff writers Posted on 06 Jan 2020 |
Image: NT-proBNP levels can predict adverse outcomes following surgery (Photo courtesy of 123rf)
A new study suggests that preoperative measurement of N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) can predict adverse outcomes after most types of surgery.
Researchers from nine countries, including the University of Montreal (Canada), McMaster University (Hamilton, ON, Canada), Hospital Israelita Albert Einstein (São Paulo, Brazil), and other institutions conducted a cohort study to examine if higher pre-operative levels of NT-proBNP can predict post-surgical cardiac and vascular complications. The study included 10,402 patients (45 years of age or older) undergoing non-cardiac surgery. All patients had NT-proBNP levels measured before surgery and troponin T levels measured daily for up to three days after surgery.
The results showed that compared with patients with preoperative NT-proBNP values less than 100 pg/mL, patients with levels of 100-200 pg/mL, 200-1,500 pg/mL, and 1500 pg/mL or greater were associated with adjusted hazard ratios of 2.27, 3.63, and 5.82, respectively. Corresponding incidences of the composite of vascular death and myocardial injury after noncardiac surgery (MINS) were 12.3% , 20.8%, and 37.5%, respectively. Preoperative NT-proBNP values were also significantly associated with 30-day all-cause mortality. The study was published on December 24, 2109, in Annals of Internal Medicine.
"Any type of surgery has the potential to cause damage to heart tissue, through blood clot formation, long periods of inflammation, or bleeding,” said senior author cardiologist Professor PJ Deveraux, MD, of McMaster University, and the Population Health Research Institute (PHRI; Hamilton, Ontario, Canada). “As a result of these findings, doctors can predict who is at greater risk of heart attacks and other negative vascular events after surgery.”
“This simple blood test can be done quickly and easily as part of patient's pre-operative evaluation, and can help patients better understand their risk of post-operative complications and make informed decisions about their surgery,” said lead author Emmanuelle Duceppe, MD, of the Centre Hospitalier de l'Universite de Montreal (CHUM; Canada), and associate researcher at PHRI. “This blood test is twenty times cheaper than more time-consuming tests such as cardiac stress tests and diagnostic imaging.”
NT-proBNP is a non-active prohormone that is released from the same molecule that produces B-type natriuretic peptide (BNP). Both BNP and NT-proBNP are released in response to changes in pressure inside the heart that are associated with heart failure (HF) and other cardiac problems. Normal levels of NT-proBNP are lower than 125 pg/mL for patients aged up to 74 years, and less than 450 pg/mL for patients aged 75-99 years.
Related Links:
University of Montreal
McMaster University
Hospital Israelita Albert Einstein
Researchers from nine countries, including the University of Montreal (Canada), McMaster University (Hamilton, ON, Canada), Hospital Israelita Albert Einstein (São Paulo, Brazil), and other institutions conducted a cohort study to examine if higher pre-operative levels of NT-proBNP can predict post-surgical cardiac and vascular complications. The study included 10,402 patients (45 years of age or older) undergoing non-cardiac surgery. All patients had NT-proBNP levels measured before surgery and troponin T levels measured daily for up to three days after surgery.
The results showed that compared with patients with preoperative NT-proBNP values less than 100 pg/mL, patients with levels of 100-200 pg/mL, 200-1,500 pg/mL, and 1500 pg/mL or greater were associated with adjusted hazard ratios of 2.27, 3.63, and 5.82, respectively. Corresponding incidences of the composite of vascular death and myocardial injury after noncardiac surgery (MINS) were 12.3% , 20.8%, and 37.5%, respectively. Preoperative NT-proBNP values were also significantly associated with 30-day all-cause mortality. The study was published on December 24, 2109, in Annals of Internal Medicine.
"Any type of surgery has the potential to cause damage to heart tissue, through blood clot formation, long periods of inflammation, or bleeding,” said senior author cardiologist Professor PJ Deveraux, MD, of McMaster University, and the Population Health Research Institute (PHRI; Hamilton, Ontario, Canada). “As a result of these findings, doctors can predict who is at greater risk of heart attacks and other negative vascular events after surgery.”
“This simple blood test can be done quickly and easily as part of patient's pre-operative evaluation, and can help patients better understand their risk of post-operative complications and make informed decisions about their surgery,” said lead author Emmanuelle Duceppe, MD, of the Centre Hospitalier de l'Universite de Montreal (CHUM; Canada), and associate researcher at PHRI. “This blood test is twenty times cheaper than more time-consuming tests such as cardiac stress tests and diagnostic imaging.”
NT-proBNP is a non-active prohormone that is released from the same molecule that produces B-type natriuretic peptide (BNP). Both BNP and NT-proBNP are released in response to changes in pressure inside the heart that are associated with heart failure (HF) and other cardiac problems. Normal levels of NT-proBNP are lower than 125 pg/mL for patients aged up to 74 years, and less than 450 pg/mL for patients aged 75-99 years.
Related Links:
University of Montreal
McMaster University
Hospital Israelita Albert Einstein
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Latest Surgical Techniques News
- Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health
- Tiny Robots Made Out Of Carbon Could Conduct Colonoscopy, Pelvic Exam or Blood Test
- Miniaturized Ultrasonic Scalpel Enables Faster and Safer Robotic-Assisted Surgery
- AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy Detects More Lesions
- First-Ever Contact Force Pulsed Field Ablation System to Transform Treatment of Ventricular Arrhythmias
- Caterpillar Robot with Built-In Steering System Crawls Easily Through Loops and Bends
- Tiny Wraparound Electronic Implants to Revolutionize Treatment of Spinal Cord Injuries
- Small, Implantable Cardiac Pump to Help Children Awaiting Heart Transplant
- Gastrointestinal Imaging Capsule a Game-Changer in Esophagus Surveillance and Treatment
- World’s Smallest Laser Probe for Brain Procedures Facilitates Ablation of Full Range of Targets
- Artificial Intelligence Broadens Diagnostic Abilities of Conventional Coronary Angiography
- AI-Powered Surgical Visualization Tool Supports Surgeons' Visual Recognition in Real Time
- Cutting-Edge Robotic Bronchial Endoscopic System Provides Prompt Intervention during Emergencies
- Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery